In summary, we have demonstrated that the functional silencing of p53 plays an important role in protecting against NAFLD by activating autophagy in vivo and in vitro via the HMGB1 pathway. Here, HMGB1 is linked to metabolic dysfunction-associated steatotic liver disease.